PDCD1 and non-small cell lung carcinoma: Vaidya et al. [22] utilized the texture and quantitative vascular tortuosity (QVT) as the training features in CT images of NSCLC patients and then, used an RF classifier to forecast progression risk in patients receiving PD-1/PD-L1 therapy.